Skip to main content
Download PDF

The effects of Mediterranean diet on cardiovascular risk factors, glycemic control and weight loss in patients with type 2 diabetes: a meta-analysis

BMC Nutrition volume 10, Article number: 59 (2024) Cite this article

Abstract

To explore the impact of the Mediterranean diet on cardiovascular risk factors, glycemic control and weight loss in patients with type 2 diabetes(T2D) by a meta-analysis of randomized controlled trials (RCTs). We systematically searched PubMed, Cochrance Library, EMBASE and four Chinese databases to identify RCTs that compared the Mediterranean diet with control diets in patients with T2D up to December 2021. The Risk of Bias of the included studies was assessed using the version 2 of the Cochrane risk-of-bias tools for randomized trials (ROB 2). Seven RCTs with 1371 patients met the eligibility criteria and entered into the meta-analysis. Compared to control diets, the beneficial effects of Mediterranean diet were not statistically significant in high-density lipoprotein (MD = 2.33; 95% CI: -0.27 to 4.92), low-density lipoprotein (MD = -2.34; 95% CI -5.67 to 0.99) and total cholesterol (MD = 2.60; 95% CI: -0.95 to 6.15). But Mediterranean diet led to reduce the level of diastolic blood pressure (MD = -1.20; 95% CI: -2.21 to -0.19) and systolic blood pressure (MD = -4.17; 95% CI: -7.12 to -1.22). Meanwhile, Mediterranean diet showed beneficial effects in glycemic control (HbA1[%]: MD = -0.39, 95% CI: -0.58 to -0.20; fasting plasma glucose: MD = -15.12, 95% CI: -24.69 to -5.55) and weight loss (BMI: MD = -0.71, 95% CI: -1.30 to -0.78; WC: MD = -1.69; 95% CI: -3.35 to -0.02) compared to the control diets. The meta-analysis presented evidence supporting the beneficial effects of the Mediterranean diet on blood pressure, glycemic control, and weight loss. However, the impact of the Mediterranean diet on the lipid profile was not found to be significant, warranting further verification. This Meta-analysis was registered on the INPLASY website (Registration number: INPLASY 202160096).

Peer Review reports

Background

Type 2 diabetes ( T2D ) is a global disease. According to the survey, as of 2017, the number of patients with T2D in the world was as high as 425 million, and the number of people who die of diabetes each year was as high as 4 million [1]. In addition, the incidence rate is gradually increasing. Experts predicted that by 2035, the number of people with diabetes will reach 592 million [2], which will pose great threat to human health and cause huge medical economic costs. T2D is mainly characterized by elevated blood glucose, insulin resistance and decreased insulin sensitivity [3]. Investigation shows that the proportion of overweight or obese people in type 2 diabetic population is as high as 90% [4]. Most diabetic patients are accompanied by metabolic syndrome such as elevated blood lipid and blood pressure, which will increase the risk of various heart diseases [5]. Therefore, it is necessary to take effective measures for comprehensive management of T2D, and it is particularly important to control blood glucose and body weight to reduce the risk of heart disease. Lifestyle interventions have been recognized by experts and scholars as an effective means for the treatment of T2D and dietary changes can effectively improve insulin sensitivity, prevent the progression of the disease and delay the occurrence of complications [6, 7]. Current studies have shown that dietary patterns such as low fat [8], low carbohydrate [9], and high monounsaturated fatty acids [10] have certain effects on blood glucose control and weight of diabetic patients, but the results are not consistent. And the American Diabetes Association stated that there was not enough evidence to recommend the correct proportion of fat, protein and carbohydrate in the diet for patients with T2D [11].

The idea that Mediterranean diet is beneficial to human health has gradually been accepted by scholars around the world. Mediterranean diet, first proposed by Ancel Key in 1960 [12], is a unique diet of people living in the Mediterranean region. The Mediterranean diet is characterized by a high proportion of vegetables, fruits, beans, seafood and nuts. Vegetable oil (mainly olive oil, rich in unsaturated fatty acids) should be used for cooking, and a low proportion of red meat and processed foods should be used, as well as red wine with each meal [13,14,15]. A meta-analysis in 2015 demonstrated that, in comparison with other diets, the Mediterranean diet is more effective in controlling blood glucose, managing body weight, and reducing the risk of heart disease in patients with Type 2 diabetes [16]. However, previous clinical trial showed that compared with the Mediterranean diet, low-carbohydrate diet can better control the risk of blood glucose and heart disease in patients with T2D [17]. Huntriss’ meta-analysis showed that reducing the proportion of carbohydrate diet can better manage T2D [18]. In addition, Mohammad's survey in 2020 showed that compared with conventional diet, Mediterranean diet could not effectively reduce body mass index (BMI) and multiple risk indicators of heart disease in patients with T2D [19]. It’s worth noting that, despite the 2015meta-analysis on the effects of the Mediterranean diet on blood glucose in diabetic patients [16], this information is now eight years old, and further research may be warranted to provide updated insights.

A network meta-analysis was conducted in 2019 [11] which compared major dietary patterns, the included RCTs were published between 2006 and 2016, Only 5 articles on the Mediterranean diet were included. In 2021 tang et al. meta-analyzed a cohort study correlating the Mediterranean diet with mortality in patients with cardiovascular disease and showed that Mediterranean diet improved survival in people with a history of CVD, But there is no validation of specific serum indicators [20]. Lotfi et al. [21] conducted a meta-analysis of prospective cohort studies of the Mediterranean diet, five-year weight change, and risk of overweight and obesity, which showed that the Mediterranean diet was inversely associated with five-year weight change and risk of overweight/obesity, but the present study meta-analysed the weight metrics of the cohort studies only, and has not yet that of the randomized cohort trial and other metrics [21]. Sarsangi et al. [22] meta-analysis of a prospective cohort study of the Mediterranean diet and risk of T2D showed that the Mediterranean diet reduces the risk of T2D, but specific indicators of the Mediterranean diet in patients with T2D have not yet been analyzed [22].

Therefore, it is not clear whether the Mediterranean diet is better at controlling glycemic, weight and reducing the risk of heart disease in people with T2D than other diets.This study conducted a meta-analysis of RCTs of Mediterranean diet in patients with T2D, so as to more comprehensively grasp the effects of Mediterranean diet on cardiovascular risk factors, glycemic control, and body weight in patients with diabetes, and provide a more effective basis for clinical practice.

Methods

This meta-analysis was conducted in accordance with the statement of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). It was registered on the INPLASY website (Registration number: INPLASY 202160096).

Literature research

A systematic literature search was conducted in three English databases (PubMed, EMBASE, Cochrance Central Register of Controlled Trials, Web of Science) and four Chinese databases (Chinese Biomedical Literature Database, Wanfang Data, Chinese National Knowledge Infrastructure, and Chinese Science and Technology Periodical Database) from inception to December 2023. The search terms comprising Medical Subject Heading (MeSH), free text and word variants were as follows: (1) Diet, Mediterranean, combined explored versions of Medical Subject Headings (Mesh) ‘Mediterranean Diet’ ‘Diets, Mediterranean’ OR ‘Mediterranean Diets’; (2) Diabetes Mellitus, Type 2 combined explored versions of Medical Subject Headings(Mesh) ‘Diabetes Mellitus, Noninsulin-Dependent’ OR ‘Diabetes Mellitus, Type II’ ‘NIDDM’ OR ‘Diabetes Mellitus, Noninsulin Dependent’ OR ‘Slow-Onset Diabetes Mellitus’ OR ‘Diabetes Mellitus, Adult Onset’ and so on.We combined these terms as follows: (1) and (2).

Study selection

Two researcher assessed literature eligibility independently (XZ, WZ). Cohen’s kappa statistics were used to assess the degree of agreement between the two reviewers. Any discordance opinions were resolved by a third researcher (XW). The selection criteria were as follows: (1) Participants comprised with already diagnosed T2D and aged ≥18 years, (2) Parallel or cross-over RCT, (3) The period of Mediterranean diet intervention at least lasted for 6 months, (4) Results reported to evaluate the effect of the Mediterranean diet including cardiovascular risk factors or HbA1c at least, (5) Studies published in English and Chinese. Exclusion criteria:type 1 diabetes and gestational diabetes. Observational studies, reviews, letters, case reports and news were excluded. All the articles eligible were identified by screening the titles or abstracts and then reviewing the full-text for further review.

Data extraction

The following information was extracted by two researchers independently from the eligible studies: the first author information, year of publication, country, the characteristics of participants (number/age/and during of T2D), period of intervention, content of Mediterranean diet intervention and control intervention, and main study finding. The main results were classified into three categories:(1) cardiovascular risk factors including total cholesterol(TC), high-density lipoprotein cholesterol(HDL), low-density lipoprotein cholesterol(LDL), systolic blood pressure(SBP) and diastolic blood pressure(DBP). (2) glycemic control including HbA1c and fasting plasma glucose(FPG), (3) weight loss including BMI, waist circumference(WC) and body weight.

Risk of bias assessment

The risk of bias of RCTs was assessed using version 2 of the Cochrane risk-of-bias tools for randomized trials (ROB 2), which included six categories: Randomization Process, Bias due to deviations from intended interventions, Bias due to missing data, Bias in measurement of outcomes, Bias in selection of the reported result and overall. The above six risk of bias domains were classified into three levels as a low risk ,some concerns and a high risk. The studies quality assessment was done independently by two researchers (XZ, WZ), any disagreement between the two researchers was solved by the third researcher (XW).

Data synthesis and analysis

Data analysis were carried out using Review Manager 5.3 software. The mean differences between Mediterranean diet and control diet with 95% confidence intervals(CIs) were calculated for continuous outcomes. 95% CIs and P-values for some studies. We used Mediterranean diet in terms of combining statistics, Variables with inconsistent units are converted to the same units and then combined for calculation. We tested for heterogeneity using I2, I2 value <25%, 25-50%, and >50% indicate low, medium and high heterogeneity respectively. I2 value greater than 50% was considered substantial. Sensitively analysis and subgroup analysis were performed to explore the potential sources of high heterogeneity.

Results

Study selection and characteristics

A total of 5418 unique citations were identified, of which 4906 records were identified through PubMed, EMBASE, Cochrance Central Register of Controlled Trials and Cochrance Database and Web of Science, 512 records were identified through Chinese Biomedical Literature Database, Wanfang Data, Chinese National Knowledge Infrastructure. 3352 records remined after removing 2066 records duplicates. After screening title and abstract, 166 records remained for full-text review. After further evaluation of full text, 152 records were excluded for not meeting the unique criteria, the excluded due to the reasons described in Fig. 1. A total 14 studies included in qualitative synthesis, of these, 4 studies were excluded for the following reasons: One study sample overlapped [23], One study the basic characteristics were significantly different between two groups [24]. One study cannot calculated the standard deviation from the data in the original study [25], 1 study was a post hoc analysis of PREDIMED study [26]. Two studies the intervention duration was 12 weeks and two weeks, which did not meet the requirement of >6 months of intervention for this study [27, 28]. One study is a registered trial with no clinical data yet available [29]. Finally, a total of 7 studies met the inclusion criteria involving 1371 patients entered into this meta-analysis.

Fig. 1
figure 1

Flow diagram of literature research and study selection

Full size image

Table 1 summarized the basic characteristics of the 7 selected studies, all of which were RCTs and published in English. The duration of the intervention ranged from 6 months to 8.1 years. The participants’ ages ranged from 25 to 75 years during the intervention. The study samples ranged from 95 to 279. 3 trials were conducted in United State, others were conducted in Israel, Italy, Iran and Spain. All of the selected trials studied the effects of Mediterranean diet on the patients with T2D. One study compared two types of Mediterranean diet versus a control diet [17], therefore, 7 RCTs with 8 arms were included in the quantitative due to treat these arms in isolation. The control diets in these selected studies comprised high-carbohydrate diet, 2003 American Diabetes Association(ADA) diet, Low-fat diet and usual dietary. All of the selected trials comprised the basic characteristics of Mediterranean diet in the intervention diets, two trials emphasized the multifactorial intervention to improve the adherence to the Mediterranean diet (Table 1).

Table 1 Characteristics of included studies
Full size table

Risk of bias assessment

Of the seven RCTs, two studies were identifified as having high risk of bias [17, 34], and five as having some concerns (Brehm et al. [30], Toobert et al. [31], Maiorino et al. [32], Maryam et al. [19], Alonso-Dominguez et al. [33]. In terms of the randomization process, four studies presented some concerns due to insufficient information on allocation concealment (Brehm et al. [30], Toobert et al. [31], Elhayany et al. [17], Maryam et al. [19]. All of the seven studies were considered to have some concerns to the risk of bias from assignment to interventions due to none of the seven studies reported the success of blinding of participants and personnel for dietary intervention. Two study had high risk of bias for missing outcome data because of a high proportion of participant loss [17, 34]. Another two studies were considered to have some concerns due to insufficient information provided about the blinding of outcome assessors (Toobert et al. [31]; Maryam et al. [19]. All of the seven studies were considered to have some concerns in the bias of reported results due to the absence of registered protocols (Table 2).

Table 2 Risk of bias of included studies
Full size table

Cardiovascular risk factors

Five studies reported the SBP and DBP data that could be pooled in the analysis. The Mediterranean diet significantly decreased the level of DBP by fixed effects model (MD = -1.20; 95% CI: -2.21 to -0.19, I2= 0 %; P = 0.02) (Fig. 2a) and could significantly reduce the level of SBP by random effects model (MD = -4.17; 95% CI: -7.13 to -1.22; I2= 60%; p = 0.006) (Fig. 2b) through compared with control diet.

Fig. 2
figure 2

Forest plot assessing the effects of Mediterranean-style diet in DBP(A), SBP(B), HDL(C) , LDL(D) and TC(E). Alonso-Dominguez 2019 is the comparison between mediterranean diet and usual care; Brehm 2009 is the comparison between mediterranean diet and High-carbohydrate diet; Elhayany 2010 is the comparison between two mediterranean diets and American Diabetes Association diet; Maiorino 2016 is the comparison between mediterranean diet and Low-fat diet; Toobert 2003 is the comparison between mediterranean diet and usual care; Zahedi 2020 is the comparison between mediterranean diet and usual care

Full size image

Changes in HDL and LDL were pooled for six studies with seven arms (n = 1181). Meta-analysis showed a trend toward reducing the level of LDL (MD = -2.34; 95% CI:-5.67 to 0.99; I2 = 13%; p = 0.17) by fixed effects model (Fig. 2c) and increasing the level of HDL (MD = 2.33; 95% CI: -0.27 ~ 4.92; I2 = 82%; p = 0.08) (Fig. 2d), but the beneficial effects of Mediterranean diet compared with control diets were not statistically significant. Moreover, Mediterranean diet could not reduce the level of TC compared with control diets (MD = 2.60; 95% CI: -0.95 ~ 6.15; I2 = 0%; p = 0.15) (Fig. 2e).

Glycemic control

The data for the change in HbA1c level were pooled from seven studies with eight arms (n = 1371). Meta-analysis showed that the Mediterranean diet was associated with a significant reduction in HbA1c compared with the control diet (MD = -0.39; 95% CI: -0.58 to -0.20; I2= 80%, p<0.001) by random effects model (Fig. 3a).

Fig. 3
figure 3

Forest plot assessing the effects of Mediterranean-style diet in HbA1c(A) and FPG(B). Alonso-Dominguez 2019 is the comparison between mediterranean diet and usual care; Brehm 2009 is the comparison between mediterranean diet and High-carbohydrate diet; Elhayany 2010 is the comparison between two mediterranean diets and AmericanDiabetes Association diet; Maiorino 2016 is the comparison between mediterranean diet and Low-fat diet; Toobert 2003 is the comparison between mediterranean diet and usual care; Zahedi 2020 is the comparison between mediterranean diet and usual care; Toobert 2011 is the comparison between mediterranean diet and usual care

Full size image

Four studies with five arms (n = 717) measured the changes in FPG. Meta-analysis showed that subjects who accepted Mediterranean diet had decreased FPG levels (MD= -15.12 mg/dl, 95% CI: -24.69 ~ -5.55; p = 0.002) compared with those who accepted control diet (Fig. 3b) by random effects model due to the high heterogeneity (I2= 68%) .

Weight loss

Changes in BMI levels were pooled for four studies with five arms. Subjects who consumed Mediterranean diet (n = 507) showed statistically significant decline in BMI (MD = -0.71; 95% CI: -1.30 to -0.78; p = 0.02) compared with subjects with control die t(n = 369) by using a fixed effects model (I2= 30%) (Fig. 4a).

Fig. 4
figure 4

Forest plot assessing the effects of Mediterranean-style diet in BMI(A), body weight(B) and WC(C). Alonso-Dominguez 2019 is the comparison between mediterranean diet and usual care; Brehm 2009 is the comparison between mediterranean diet and High-carbohydrate diet; Elhayany 2010 is the comparison between two mediterranean diets and AmericanDiabetes Association diet; Maiorino 2016 is the comparison between mediterranean diet and Low-fat diet; Toobert 2003 is the comparison between mediterranean diet and usual care; Zahedi 2020 is the comparison between mediterranean diet and usual care

Full size image

Only three studies with four arms (n = 489) reported data on body weight, the reduction in body weight was not statistically significant trough Mediterranean diet compared with control diet (MD = -1.24; 95% CI: -3.23 to 0.74; p = 0.22) by fixed effects model due to no heterogeneity was observed (I2= 0.0%) (Fig. 4b).

In additional, three studies with four arms (n = 579) measured the WC and were pooled in the analysis. There was a statistically significant decline in WC level between Mediterranean diet and control diets by a fixed effects model (MD = -1.69; 95% CI:-3.35 to -0.02; I2= 0 %; p = 0.05) (Fig. 4c).

Publication bias

The funnel plot showed some evidence of potential publication bias for HbA1c, FPG, SDP and HDL, there were no evidence of substantial publication bias for the other measurement index (BMI, body weight, WC, BDP, TC and LDL).

Sensitivity analysis and subgroup

In the sensitivity analysis, the pooled effects can not alter by omission of any individual study from the meta-analysis in the level of HbA1c. When we excluded one study with Zahedi 2020 in SBP, the heterogeneity was changed (I2= 0 %), the effect estimate was unchanged by the Fixed effects model (MD -2.73; 95% CI -4.72 ~ -0.74; I2 = 0 %; P = 0.007) (Fig. 5). When we excluded one study with Zahedi 2020 in FPG, the heterogeneity was changed (I2= 44 %), the effect estimate was unchanged by the Fixed effects model (MD -10.73; 95% CI -16.09 ~ -5.38; I2 = 44 %; P < 0.001) (Fig. 5). But changes in the HDL, when we excluded one study with two arms (Elhayany 2010), the heterogeneity was changed (I2= 56%), the effect estimate was unchanged by the random effects model (MD 0.75; 95% CI -1.22 ~ 2.73; I2 = 56%; P = 0.46) (Fig. 5), the result show Mediterranean diet cannot improve the level of HDL compared with the control diet.

Fig. 5
figure 5

SBP(A), HDL(B), FPG(C) after the sensitivity analysis by excluding study. Alonso-Dominguez 2019 is the comparison between mediterranean diet and usual care; Brehm 2009 is the comparison between mediterranean diet and High-carbohydrate diet; Elhayany 2010 is the comparison between two mediterranean diets and American Diabetes Association diet; Maiorino 2016 is the comparison between mediterranean diet and Low-fat diet; Toobert 2003 is the comparison between mediterranean diet and usual care; Zahedi 2020 is the comparison between mediterranean diet and usual care

Full size image

High heterogeneity were found in the primary outcomes of HbA1c and HDL, therefore the subgroup analysis was performed for further analysis. The subgroup analyses in HbA1c levels were stratified by country, number of participants, disease characteristics of participants and quality of the selected studies. The results by the subgroup analysis were similar to the primary analysis (Table 3). However, subgroup analyses of HDL according to the study population showed that heterogeneity was still high, and subgroup analyses of SBP and FPG were not possible due to the small number of included studies in the literature.

Table 3 Subgroup analyses for primary outcome of HbA1c
Full size table

Discussion

Meta-analysis of the RCTs that met the inclusion criteria showed that Mediterranean diet could better control glycemic, reduce the BMI and blood pressure in patients with T2D, but the improvement effects on HDL, LDL and TC were not obviously and needed to be further verified.

In this meta-analysis, although the Mediterranean diet did not reach statistical significance in terms of its effect on HDL and LDL compared to the control group, there was still a tendency to increase HDL and decrease LDL levels, as well as the Mediterranean diet reduced the levels of SBP and DBP, which fully validates that the Mediterranean diet reduces the risk of heart disease in patients with T2D. Studies have shown that every 0.1% decrease in HbA1c level can reduce the risk index of heart disease by 7% [35]. Intake of 10g of olive oil per day can reduce the risk of heart disease by 16% [36, 37]. Conducted a Real Life Study on the composition of each food in Mediterranean diet, the results showed that cardiovascular risk factors was reduced by 21% in the high Mediterranean diet group compared with the low Mediterranean diet group. Increasing the proportion of vegetables and fruits can make the goal of lowering LDL easier to achieve, and increasing fish intake can significantly reduce TC levels. However, in this study, the effects of Mediterranean diet on HDL and LDL have not reached statistical significance, and the TC level cannot be effectively reduced, which is somewhat different from the conclusions of previous studies, and may be partly related to the large difference in the baseline level of serum indicators (HDL/LDL/TC) of the two groups of subjects in only 6 literatures included in this study. Therefore, the effect of Mediterranean diet on HDL and LDL still needs to be further verified.

Mediterranean diet can reduce the levels of HbA1c and FPG in patients with T2D, which is consistent with the results of two meta-analyses in 2013 and 2015 [16, 38]. This may be associated with a high proportion of vegetables, monounsaturated fatty acids, nuts and fruits in Mediterranean diet. This kind of food can effectively improve insulin sensitivity and prevent production of advanced glycosylated end products and other factors [39]. However, the degree to which Mediterranean diet reduced HbA1c was strongly related to the type of diet compared. In addition, there are certain differences in the level of HbA1c reduction compared with different diet types. Compared with conventional diet, Mediterranean diet can reduce HbA1c level by 0.53 [16], but compared with low-fat diet, Mediterranean diet can only reduce HbA1c by 0.32 [40]. Moreover, the research results of Snorgaard et al [41] showed that low-fed diets achieved higher rates of diabetes remission (defined as HbA1c <6.5%) compared with control diets. Therefore, the study showed that low-fed diets could more effectively manage HbA1c in patients with age over 60 years old, while Mediterranean diet had better effect on patients with age under 60 years old. In addition, studies have shown that Mediterranean diet can reduce insulin resistance [16]. However, due to the few literatures included in this meta-analysis that included this indicator, the effect of Mediterranean diet on insulin resistance was not analyzed.

Mediterranean diet can reduce the BMI and WC of patients with T2D, which is consistent with the results of many previous studies [11, 16, 41], and may be related to the fact that Mediterranean diet is rich in a large number of vegetable, grain and other plant foods, which provide more dietary fiber and reduce the load of carbohydrates. Moreover, the research results of Hashimoto et al. [42] showed that low-fed diets can better manage body weight and fat mass compared with Mediterranean diet which may be related to the age of the research object in the included literature to some extent. However, in this meta-analysis, the effect of Mediterranean diet on the reduction of WC was not obvious, possibly because there were only 3 studies that included WC in the outcome variables in the included literatures in this meta-analysis, and the results may be biased to some extent.

Each component of the special diet of Mediterranean diet can have a great correlation with the homeostasis of diabetes, and many effects may have common physiological and pathological pathways. Mediterranean diet not only plays an obvious role in blood glucose control, weight reduction, and risk reduction of heart disease, etc. Furthermore, studies have shown that Mediterranean diet affects glucagon‐like peptide 1 [42], oxyntomodulin [43], postprandial lipemia [44], and antioxidant/ antioxidant enzymes compounds [45], gut microbiota composition and function [46, 47], branched chain aminoacid management [48] and many other aspects have certain significance. Therefore, under the synergistic effect of various components in Mediterranean diet, Mediterranean diet becomes a valuable dietary pattern for primary and secondary prevention of diabetes and gradually becomes a healthy and nutritious dietary lifestyle. However, there are still some differences in the results of group multi-action, which need to be further verified.

Therefore, in the future, scholars should pay more attention to the study of objective clinical indicators, such as heart disease risk indicators, in order to provide a more accurate theoretical basis for clinical practice. As there are various types of diabetes diets, scholars could employ Network Meta-analysis in the future to potentially yield more accurate results.

Limitations

This meta-analysis includes seven RCTs involving a total of 1371 patients with T2D, Several limitations should be recognized. First, the participants in this study were all diabetic patients, and there was no study on non-diabetic patients. According to the survey by Carter et al. on all populations with or without diabetes, Mediterranean diet can only reduce the level of HbA1c, but its effect on FPG is not obvious [49]. Furthermore, the control group in this study included various diets, which may have a certain influence on the results of the study, because the role of different diets in different studies varies to a certain extent. Finally, the relatively insufficient number of trials limits our ability to conduct further subgroup analysis on some specific indicators.

Conclusion

This meta-analysis provides convincing evidence for helping health administrators to identify effective dietary strategy for patients with T2D. The results reveal that Mediterranean diet has a more prominent role in management of T2D, which is effective in control blood pressure (DBP and SBP), glycemic control (HbA1c and FPG), losing weight (BMI and WC), but the beneficial effects in meliorate lipid were not statistically significant (HDL, LDL and TC) compared with control diets, which need to further verification.

Availability of data and materials

Data materials are real and available. Xing ZHENG should be contacted if someone wants to request the data from this study.

Abbreviations

T2D:

Type 2 Diabetes

RCTs:

Randomized Controlled Trials

ROB 2:

Cochrane risk-of-bias tools for randomized trials

HDL:

High-density lipoprotein

LDL:

Low-density lipoprotein

SBP:

Systolic blood pressure

DBP:

Diastolic blood pressure

FPG:

Fasting plasma glucose

PRISMA:

Preferred Reporting Items for Systematic reviews and Meta-Analyses

MeSH:

Medical Subject Heading

WC:

Waist circumference

BMI:

Body mass index

CIs:

Confidence intervals

References

  1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation; 2017.

    Google Scholar 

  2. International Diabetes Federation. IDF diabetes atlas. 6th ed. 2013. http://www.idf.org/diabetesatlas. Accessed 12 Nov 2016.

  3. WHO. Fact Sheet No. 312: Diabetes. Geneva: WHO; 2013.

    Google Scholar 

  4. Carter P, Khunti K, Davies MJ. Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of nutrition and metabolism. 2012;2012: 847202. https://doi.org/10.1155/2012/847202.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med. 2015;373(18):1720–32. https://doi.org/10.1056/NEJMoa1504347.

    Article  CAS  PubMed  Google Scholar 

  6. Jannasch F, Kröger J, Schulze MB. Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies. J Nutr. 2017;147(6):1174–82. https://doi.org/10.3945/jn.116.242552.

    Article  CAS  PubMed  Google Scholar 

  7. Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt TJ. Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;165(7):491–500. https://doi.org/10.7326/M16-0361.

    Article  PubMed  Google Scholar 

  8. Breukelman GJ, Basson AK, Djarova TG, Shaw BS, du Preez CJ, Shaw I. Establishing a proof of concept for the effects of low-carbohydrate, high-fat diet (LCHFD) and physical activity on body composition in type 2 diabetes. Heliyon. 2021;7(2): e06266. https://doi.org/10.1016/j.heliyon.2021.e06266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Athinarayanan SJ, Hallberg SJ, McKenzie AL, Lechner K, King S, McCarter JP, Volek JS, Phinney SD, Krauss RM. Correction to: Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):37. https://doi.org/10.1186/s12933-021-01214-9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;4(12):1989–2007. https://doi.org/10.3390/nu4121989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pan B, Wu Y, Yang Q, Ge L, Gao C, Xun Y, Tian J, Ding G. The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: A network meta-analysis. J Evid Based Med. 2019;12(1):29–39. https://doi.org/10.1111/jebm.12312.

    Article  PubMed  Google Scholar 

  12. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124(6):903–15. https://doi.org/10.1093/oxfordjournals.aje.a114480.

    Article  CAS  PubMed  Google Scholar 

  13. Fundación dieta mediterránea. Available online: https://dietamediterranea.com. Accessed 22 July 2020.

  14. Tosti V, Bertozzi B, Fontana L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. The J Gerontol A Biol Sci Med Sci. 2018;73(3):318–26. https://doi.org/10.1093/gerona/glx227.

    Article  CAS  PubMed  Google Scholar 

  15. Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care. 2014;37(7):1824–30. https://doi.org/10.2337/dc13-289.

    Article  CAS  PubMed  Google Scholar 

  16. Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, Yu X. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr. 2015;69(11):1200–8. https://doi.org/10.1038/ejcn.2014.243.

    Article  CAS  PubMed  Google Scholar 

  17. Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab. 2010;12(3):204–9. https://doi.org/10.1111/j.1463-1326.2009.01151.x.

    Article  CAS  PubMed  Google Scholar 

  18. Huntriss R, Campbell M, Bedwell C. The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2018;72(3):311–25. https://doi.org/10.1038/s41430-017-0019-4.

    Article  CAS  PubMed  Google Scholar 

  19. Maryam Z, Seyed AA, Maryam A, Reza A, Seyed AH, Arash RS. Efficacy of mediterranean diet on blood biochemical factors in type II diabetic patients: a randomized controlled trial. GMJ. 2020;31:714–8.

    Google Scholar 

  20. Tang C, Wang X, Qin LQ, Dong JY. Mediterranean Diet and Mortality in People with Cardiovascular Disease: A Meta-Analysis of Prospective Cohort Studies. Nutrients. 2021;13(8):2623. https://doi.org/10.3390/nu13082623.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lotfi K, Saneei P, Hajhashemy Z, Esmaillzadeh A. Adherence to the mediterranean diet, five-year weight change, and risk of overweight and obesity: a systematic review and dose-response meta-analysis of prospective cohort studies. Adv Nutr (Bethesda, Md). 2022;13(1):152–66.

    Article  CAS  Google Scholar 

  22. Sarsangi P, Salehi-Abargouei A, Ebrahimpour-Koujan S, Esmaillzadeh A. Association between adherence to the mediterranean diet and risk of type 2 diabetes: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Advances in nutrition (Bethesda, Md). 2022;13(5):1787–98.

    Article  PubMed  Google Scholar 

  23. Esposito K, Maiorino MI, Ciotola M, Di Palo C, Scognamiglio P, Gicchino M, Petrizzo M, Saccomanno F, Beneduce F, Ceriello A, Giugliano D. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med. 2009;151(5):306–14. https://doi.org/10.7326/0003-4819-151-5-200909010-00004.

    Article  PubMed  Google Scholar 

  24. Monlezun DJ, Kasprowicz E, Tosh KW, Nix J, Urday P, Tice D, Sarris L, Harlan TS. Medical school-based teaching kitchen improves HbA1c, blood pressure, and cholesterol for patients with type 2 diabetes: Results from a novel randomized controlled trial. Diabetes Res Clin Pract. 2015;109(2):420–6. https://doi.org/10.1016/j.diabres.2015.05.007.

    Article  PubMed  Google Scholar 

  25. Pérez-Ferre N, Del Valle L, Torrejón MJ, Barca I, Calvo MI, Matía P, Rubio MA, Calle-Pascual AL. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: A three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups. Clinical nutrition (Edinburgh, Scotland). 2015;34(4):579–85. https://doi.org/10.1016/j.clnu.2014.09.005.

    Article  CAS  PubMed  Google Scholar 

  26. Basterra-Gortari FJ, Ruiz-Canela M, Martínez-González MA, Babio N, Sorlí JV, Fito M, Ros E, Gómez-Gracia E, Fiol M, Lapetra J, Estruch R, Serra-Majem L, Pinto X, González JI, Bulló M, Castañer O, Alonso-Gómez Á, Forga L, Arós F, PREDIMED Study Investigators. Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial. Diabetes Care. 2019;42(8):1390–7. https://doi.org/10.2337/dc18-2475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gardner CD, Landry MJ, Perelman D, Petlura C, Durand LR, Aronica L, Crimarco A, Cunanan KM, Chang A, Dant CC, Robinson JL, Kim SH. Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: The interventional Keto-Med randomized crossover trial. Am J Clin Nutr. 2022;116(3):640–52. https://doi.org/10.1093/ajcn/nqac1543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rein M, Ben-Yacov O, Godneva A, Shilo S, Zmora N, Kolobkov D, Cohen-Dolev N, Wolf BC, Kosower N, Lotan-Pompan M, Weinberger A, Halpern Z, Zelber-Sagi S, Elinav E, Segal E. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial. BMC Med. 2022;20(1):56. https://doi.org/10.1186/s12916-022-02254-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Papamichou D, Panagiotakos DB, Holmes E, Koutsakis P, Katsoulotos H, Loo RL, Itsiopoulos C. The rationale and design of a Mediterranean diet accompanied by time restricted feeding to optimise the management of type 2 diabetes: The MedDietFast randomised controlled trial. Nutr Metab Cardiovasc Dis. 2022;32(1):220–30. https://doi.org/10.1016/j.numecd.2021.09.031.

    Article  CAS  PubMed  Google Scholar 

  30. Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D’Alessio DA. One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Diabetes Care. 2009;32(2):215–20. https://doi.org/10.2337/dc08-0687.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Toobert DJ, Glasgow RE, Strycker LA, Barrera M Jr, Radcliffe JL, Wander RC, Bagdade JD. Biologic and quality-of-life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care. 2003;26(8):2288–93. https://doi.org/10.2337/diacare.26.8.2288.

    Article  PubMed  Google Scholar 

  32. Maiorino MI, Bellastella G, Petrizzo M, Gicchino M, Caputo M, Giugliano D, Esposito K. Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes: Follow-up of a randomized trial. Eur J Prev Cardiol. 2017;24(4):399–408. https://doi.org/10.1177/2047487316676133.

    Article  PubMed  Google Scholar 

  33. Alonso-Domínguez R, García-Ortiz L, Patino-Alonso MC, Sánchez-Aguadero N, Gómez-Marcos MA, Recio-Rodríguez JI. Effectiveness of A Multifactorial Intervention in Increasing Adherence to the Mediterranean Diet among Patients with Diabetes Mellitus Type 2: A Controlled and Randomized Study (EMID Study). Nutrients. 2019;11(1):162.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Toobert DJ, Strycker LA, King DK, Barrera M Jr, Osuna D, Glasgow RE. Long-term outcomes from a multiple-risk-factor diabetes trial for Latinas: ¡Viva Bien! Translational behavioral medicine. 2011;1(3):416–26. https://doi.org/10.1007/s13142-010-0011-1.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Collaboration ERF, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Danesh J. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;311(12):1225–33. https://doi.org/10.1001/jama.2014.1873.

    Article  CAS  Google Scholar 

  36. Guasch-Ferré M, Hu FB, Martínez-González MA, Fitó M, Bulló M, Estruch R, Ros E, Corella D, Recondo J, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Muñoz MA, Pintó X, Lamuela-Raventós RM, Basora J, Buil-Cosiales P, Sorlí JV, Ruiz-Gutiérrez V, … Salas-Salvadó J. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014;12:78. https://doi.org/10.1186/1741-7015-12-78.

  37. Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, Perriello G, Squatrito S, Buzzetti R, Sartore G, Babini AC, Gregori G, Giordano C, Clemente G, Grioni S, Dolce P, Riccardi G, Vaccaro O, TOSCA, IT Study Group. Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study. Nutrients. 2018;10(8):1067. https://doi.org/10.3390/nu10081067.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–16. https://doi.org/10.3945/ajcn.112.042457.

    Article  CAS  PubMed  Google Scholar 

  39. Xiao JB, Högger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015;22(1):23–38. https://doi.org/10.2174/0929867321666140706130807.

    Article  CAS  PubMed  Google Scholar 

  40. Schwingshackl L, Missbach B, König J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1292–9. https://doi.org/10.1017/S1368980014001542.

    Article  PubMed  Google Scholar 

  41. Snorgaard O, Poulsen GM, Andersen HK, Astrup A. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1).https://doi.org/10.1136/bmjdrc-2016-000354.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hashimoto Y, Fukuda T, Oyabu C, Tanaka M, Asano M, Yamazaki M, Fukui M. Impact of low-carbohydrate diet on body composition: meta-analysis of randomized controlled studies. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2016;17(6):499–509. https://doi.org/10.1111/obr.12405.

    Article  CAS  PubMed  Google Scholar 

  43. Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, Rampa L, Rossini G, Kyanvash S, Soare A, Rosati M, Piccoli A, Napoli N, Fioriti E, Pozzilli P, Khazrai YM, Manfrini S. The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial. Diabetes Metab Res Rev. 2021;37(6): e3406. https://doi.org/10.1002/dmrr.3406.

    Article  CAS  PubMed  Google Scholar 

  44. Gomez-Marin B, Gomez-Delgado F, Lopez-Moreno J, Alcala-Diaz JF, Jimenez-Lucena R, Torres-Peña JD, Garcia-Rios A, Ortiz-Morales AM, Yubero-Serrano EM, Del Mar Malagon M, Lai CQ, Delgado-Lista J, Ordovas JM, Lopez-Miranda J, Perez-Martinez P. Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trial. Am J Clin Nutr. 2018;108(5):963–70. https://doi.org/10.1093/ajcn/nqy144.

    Article  PubMed  Google Scholar 

  45. Maiorino MI, Bellastella G, Petrizzo M, Scappaticcio L, Giugliano D, Esposito K. Mediterranean diet cools down the inflammatory milieu in type 2 diabetes: the MÉDITA randomized controlled trial. Endocrine. 2016;54(3):634–41. https://doi.org/10.1007/s12020-016-0881-1.

    Article  CAS  PubMed  Google Scholar 

  46. Urpi-Sarda M, Almanza-Aguilera E, Llorach R, Vázquez-Fresno R, Estruch R, Corella D, Sorli JV, Carmona F, Sanchez-Pla A, Salas-Salvadó J, Andres-Lacueva C. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants. Diabetes Metab. 2019;45(2):167–74. https://doi.org/10.1016/j.diabet.2018.02.006.

    Article  CAS  PubMed  Google Scholar 

  47. Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(1):35–56. https://doi.org/10.1038/s41575-018-0061-2.

    Article  CAS  PubMed  Google Scholar 

  48. Zhenyukh O, Civantos E, Ruiz-Ortega M, Sánchez MS, Vázquez C, Peiró C, Egido J, Mas S. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radical Biol Med. 2017;104:165–77. https://doi.org/10.1016/j.freeradbiomed.2017.01.009.

    Article  CAS  Google Scholar 

  49. Carter P, Achana F, Troughton J, Gray LJ, Khunti K, Davies MJ. A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2014;27(3):280–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Thank you for all the preliminary results included in this study. The authors would like to thank all the participants who patiently participated in these studies.

Funding

This study was funded by the research grants from China Natural Science Foundation (CNSF) (72274110).

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P.R. China

    Xing Zheng & Aijun Wang

  2. Department of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P.R. China

    Wenwen Zhang

  3. School of Nursing, Yangzhou University, Yangzhou, Jiangsu, 225000, P. R. China

    Xiaojuan Wan

  4. Department of Nursing, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China

    Xiaoyan Lv & Yingjuan Cao

  5. Department of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China

    Peng Lin

  6. Institute for Medical Dataology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China

    Shucheng Si & Fuzhong Xue

  7. Theory & Practice Innovation Research Center, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China

    Yingjuan Cao

Authors
  1. Xing Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenwen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaojuan Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoyan Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peng Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shucheng Si
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fuzhong Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aijun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yingjuan Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Xing Zheng and Yingjuan Cao designed the manuscript. Xing Zheng, Wenwen Zhang, and Xiaojuan Wan selected the study, extracted data, and assessed the risk of bias. Xing Zheng, Fuzhong Xue, and Shucheng Si analyzed the data. Peng Lin and Aijun Wang were responsible for professional consultation. Xing Zheng and Xiaoyan Lv Drafted the manuscript. Yingjuan Cao Critical was responsible for the revision of the manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Yingjuan Cao.

Ethics declarations

Ethics approval and consent to participate

The study has been approved by the ethics Committee of the School of Public Health of Shandong University, Shandong, P. R. China (Registration number: LL20191120). This meta-analysis was registered on the INPLASY website (Registration number: INPLASY 202160096).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

 Fourteen of studies included in qualitative synthesis, 7 of records excluded table.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, X., Zhang, W., Wan, X. et al. The effects of Mediterranean diet on cardiovascular risk factors, glycemic control and weight loss in patients with type 2 diabetes: a meta-analysis. BMC Nutr 10, 59 (2024). https://doi.org/10.1186/s40795-024-00836-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40795-024-00836-y

Keywords

BMC Nutrition

ISSN: 2055-0928

Contact us